This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v1.0.0: STU 1) based on FHIR R4. The current version which supercedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions
Source view
{ "resourceType" : "ValueSet", "id" : "mcode-histology-morphology-behavior-vs", "text" : { "status" : "generated", "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h2>Histology Morphology Behavior Value Set</h2><div><p>Codes representing the structure, arrangement, and behavioral characteristics of malignant neoplasms, and cancer cells. Inclusion criteria: in situ neoplasms and malignant neoplasms. Exclusion criteria: benign neoplasms and neoplasms of unspecified behavior. Note: As the vocabulary binding is extensible within this IG, ICD-O-3 morphology codes (including behavior suffix) may also be used; they are not included in the value set for intellectual property reasons. For primary cancers, the ICD-O-3 behavior suffix should be /1, /2, or /3. For secondary cancers, the ICD-O-3 behavior suffix should be /6. Only SNOMED CT and ICD-O-3 are considered conformant to the specification. However, to be compliant with US Core Profiles, ICD-O-3 may only be used if there is no suitable code in SNOMED CT.</p>\n</div><ul><li>Include codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 367651003 (Malignant Neoplasm (Morphology))</li><li>Include codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 399919001 (Carcinoma in situ - category (morphologic abnormality))</li><li>Include codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 399983006 (In situ adenomatous neoplasm - category (morphologic abnormality))</li><li>Include these codes as defined in <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&conceptId1=399878004\">399878004</a></td><td>Malignant neoplasm with pilar differentiation (morphologic abnormality)</td><td/></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&conceptId1=253035009\">253035009</a></td><td>In situ melanocytic morphology (morphologic abnormality)</td><td/></tr></table></li><li>Exclude codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 450893003 (Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia (morphologic abnormality))</li><li>Exclude codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 128640002 (Prostatic intraepithelial neoplasia, grade III)</li><li>Exclude codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 450890000 (Glandular intraepithelial neoplasia, low grade)</li><li>Exclude codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept is-a 703548001 (Atypical hyperplasia of the endometrium)</li></ul><p>This value set includes codes based on the following rules:</p></div>" }, "url" : "http://hl7.org/fhir/us/mcode/ValueSet/mcode-histology-morphology-behavior-vs", "version" : "1.0.0", "name" : "HistologyMorphologyBehaviorVS", "title" : "Histology Morphology Behavior Value Set", "status" : "active", "date" : "2020-03-18T15:32:10+00:00", "publisher" : "HL7 International Clinical Interoperability Council", "contact" : [ { "name" : "HL7 International Clinical Interoperability Council", "telecom" : [ { "system" : "url", "value" : "http://www.hl7.org/Special/committees/cic" }, { "system" : "email", "value" : "ciclist@lists.HL7.org" } ] } ], "description" : "Codes representing the structure, arrangement, and behavioral characteristics of malignant neoplasms, and cancer cells. Inclusion criteria: in situ neoplasms and malignant neoplasms. Exclusion criteria: benign neoplasms and neoplasms of unspecified behavior. Note: As the vocabulary binding is extensible within this IG, ICD-O-3 morphology codes (including behavior suffix) may also be used; they are not included in the value set for intellectual property reasons. For primary cancers, the ICD-O-3 behavior suffix should be /1, /2, or /3. For secondary cancers, the ICD-O-3 behavior suffix should be /6. Only SNOMED CT and ICD-O-3 are considered conformant to the specification. However, to be compliant with US Core Profiles, ICD-O-3 may only be used if there is no suitable code in SNOMED CT.", "compose" : { "include" : [ { "system" : "http://snomed.info/sct", "filter" : [ { "property" : "concept", "op" : "is-a", "value" : "367651003" } ] }, { "system" : "http://snomed.info/sct", "filter" : [ { "property" : "concept", "op" : "is-a", "value" : "399919001" } ] }, { "system" : "http://snomed.info/sct", "filter" : [ { "property" : "concept", "op" : "is-a", "value" : "399983006" } ] }, { "system" : "http://snomed.info/sct", "concept" : [ { "code" : "399878004", "display" : "Malignant neoplasm with pilar differentiation (morphologic abnormality)" }, { "code" : "253035009", "display" : "In situ melanocytic morphology (morphologic abnormality)" } ] } ], "exclude" : [ { "system" : "http://snomed.info/sct", "filter" : [ { "property" : "concept", "op" : "is-a", "value" : "450893003" } ] }, { "system" : "http://snomed.info/sct", "filter" : [ { "property" : "concept", "op" : "is-a", "value" : "128640002" } ] }, { "system" : "http://snomed.info/sct", "filter" : [ { "property" : "concept", "op" : "is-a", "value" : "450890000" } ] }, { "system" : "http://snomed.info/sct", "filter" : [ { "property" : "concept", "op" : "is-a", "value" : "703548001" } ] } ] } }